Shire receives new bid from Takeda as takeover deadline looms

LONDON (Reuters) - Japan's Takeda Pharmaceutical has sweetened its $62 billion bid for Shire as it races to agree terms with the drugmaker before a deadline to strike a deal expires on Wednesday.